DSD-T309
Congenital Adrenal Hyperplasia (CAH) · 46,XX · DSD-T309
46,XY DSD due to 3β-hydroxysteroid dehydrogenase type 2 deficiency (classic salt-wasting form).
Case fields and evidence
- Category
-
Congenital Adrenal Hyperplasia (CAH)
- Age
-
Neonate (initial workup on day 3 of life, hyponatremia on day 18)
- Sex
-
Male (male sex of rearing, 46,XY)
- Karyotype
-
46,XX
- Genetics
-
SRY
- Phenotypes
-
Hypogonadism (HP:0000135); Gynecomastia (HP:0000771)
- Diagnosis
-
46,XY DSD due to 3β-hydroxysteroid dehydrogenase type 2 deficiency (classic salt-wasting form).
- Follow-up
-
Not reported in the original article (under follow-up)
- General phenotype
-
Neonatal hyperpigmentation and undervirilization; no skeletal malformations commonly seen in POR deficiency.
- Imaging
-
Not reported in the original article
- Laboratory findings
-
17-OHP 86 ng/mL, ACTH 250 pg/mL, cortisol 42 μg/L (60–230), DHEAS 1970 μg/L, testosterone 1.3 ng/mL, Δ4-androstenedione 18.5 ng/mL, DHT 26 pg/mL; renin, aldosterone, and electrolytes were normal at initial workup.
- Management
-
Started on hydrocortisone 35 mg/m²/day; on day 18, fludrocortisone 0.05 mg/day and oral NaCl 1 g/day were added.
- Pathology
-
Not reported in the original article
- Evidence level
-
See source
- Clinical history
-
See source
Cite this resource
DSD Research Library | Congenital Adrenal Hyperplasia (CAH) · 46,XX · DSD-T309 | v1.4.0 | 2026-11-17 | https://dsdatlas.com/en/cases/DSD-T309?version=v1.4.0